Physician profile
Suzanne Elyse Bile
NPI 1265913024
$4,830.02
in general payments reported to CMS, 2019-2025
16 companies · $1,035 in 2025
The $1,035 reported for 2025 was more than what 81% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,740 · 2022: $914 · 2023: $144 · 2024: $997 · 2025: $1,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,175.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $1,061.58 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Abbvie INC. | $797.47 | 2021-2025 | |
| Lundbeck LLC | $595.88 | 2021-2025 | Abilify Asimtufii, Rexulti, Brintellix |
| Neurocrine Biosciences, INC. | $380.75 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $369.51 | 2021-2025 | Caplyta |
| Alkermes, INC. | $324.87 | 2021-2025 | Lybalvi |
| Janssen Pharmaceuticals, INC | $290.84 | 2021-2025 | Invega Sustenna, Spravato |
| Vanda Pharmaceuticals INC. | $254.67 | 2021-2025 | Fanapt |
| Takeda Pharmaceuticals U.S.A., INC. | $208.72 | 2021-2025 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $169.13 | 2021-2024 | Uzedy, Austedo |
| Indivior INC. | $103.71 | 2021-2025 | Sublocade |
| E.R. Squibb & Sons, L.L.C. | $98.26 | 2024-2025 | Cobenfy |
| Corium, LLC | $55.52 | 2022-2024 | Azstarys |
| Brainsway USA INC | $46.30 | 2024 | Brainsway Deep Tms System |
| Axsome Therapeutics, INC. | $45.90 | 2024-2025 | Auvelity |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $26.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Bile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.